Auto-tuning for Model Predictive Controllers in Patients with Type 1 Diabetes

被引:0
作者
Sereno, Juan E. [1 ,2 ]
Rivadeneira, Pablo S. [1 ,2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, Grp Control Proc, INTEC, Guemes 3450, RA-3000 Santa Fe, Argentina
[2] Univ Nacl Colombia, Fac Minas, Grp GITA, Cra 80 65-223, Medellin, Colombia
来源
2018 ARGENTINE CONFERENCE ON AUTOMATIC CONTROL (AADECA) | 2018年
关键词
Artificial Pancreas; Type; 1; Diabetes; Predictive Control; Auto-tining; Nelder-Mead Method; MPC; TRIALS;
D O I
暂无
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Current proposals in glucose control using closed-loop systems have focused on maintaining blood glucose in a safe range, this against disturbances as meal intake or exercise. Due of its clinical performance, Model predictive control has been positioned as one of the most used control algorithms in the artificial pancreas. However, the personalization of this control strategy is an unresolved issue and little addressed in the literature. In this work, an auto-tuning methodology for MPC controller on type 1 diabetes patients is presented. The tuning is done through the nelder-mead method to find the controller's parameters that maximizes the time inside the normoglycemia range (70 - 180 mg/dl). It is chosen as variables to tune the weighting coefficient of the output and input, the predictive horizon, and the minimum and maximum values of the target zone. The results obtained show that auto-tuning methodology allow an increase up to 54.43% of time in normoglycemia, with an average increase up to 17.21%.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Feedback and feedforward control in the context of model predictive control with application to the management of type 1 diabetes mellitus
    Goodwin, Graham C.
    Seron, Maria M.
    CONTROL ENGINEERING PRACTICE, 2019, 89 : 228 - 237
  • [32] Variable structure-based controllers applied to the modified Hovorka model for type 1 diabetes
    Iqra Shafeeq Mughal
    Luca Patanè
    Maria Gabriella Xibilia
    Riccardo Caponetto
    International Journal of Dynamics and Control, 2023, 11 : 3159 - 3175
  • [33] Predictive model for recurrent myocardial infarction in patients with type 2 diabetes mellitus
    Koteliukh, Mariia
    MEDICAL SCIENCE, 2022, 26 (128)
  • [34] Bihormonal Model Predictive Control of Blood Glucose in People with Type 1 Diabetes
    Batora, Vladimir
    Tarnik, Marian
    Murgas, Jan
    Schmidt, Signe
    Norgaard, Kirsten
    Poulsen, Niels Kjostad
    Madsen, Henrik
    Jorgensen, John Bagterp
    2014 IEEE CONFERENCE ON CONTROL APPLICATIONS (CCA), 2014, : 1693 - 1698
  • [35] Gaussian Process-Based Model Predictive Control of Blood Glucose for Patients with Type 1 Diabetes Mellitus
    Ortmann, Lukas
    Shi, Dawei
    Dassau, Eyal
    Doyle, Francis J., III
    Leonhardt, Steffen
    Misgeld, Berno J. E.
    2017 11TH ASIAN CONTROL CONFERENCE (ASCC), 2017, : 1092 - 1097
  • [36] Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes
    Hadjadj, S
    Duly-Bouhanick, B
    Bekherraz, A
    Bridoux, F
    Gallois, Y
    Mauco, G
    Ebran, JM
    Marre, M
    DIABETES & METABOLISM, 2004, 30 (01) : 43 - 51
  • [37] Insulin auto-immunity: implications for the prevention of Type 1 diabetes mellitus
    Wicklow, Brandy A.
    Polychronakos, Constantin
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (01) : 55 - 62
  • [38] Predictive Factors for Urinary Tract Infections in Patients with Type 2 Diabetes
    Sorescu, Teodora
    Cosnita, Andrei
    Braha, Adina
    Timar, Romulus
    Timar, Bogdan
    Licker, Monica
    Lazar, Sandra
    Gaita, Laura
    Albai, Oana
    Popescu, Simona
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [39] Latent Variables Model Based MPC for People with Type 1 Diabetes
    Sun, Xiaoyu
    Rashid, Mudassir
    Askari, Mohammad Reza
    Cinar, Ali
    IFAC PAPERSONLINE, 2021, 54 (03): : 294 - 299
  • [40] Clinically Accurate Prediction of Glucose Levels in Patients with Type 1 Diabetes
    Amar, Yotam
    Shilo, Smadar
    Oron, Tal
    Amar, Eran
    Phillip, Moshe
    Segal, Eran
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (08) : 562 - 569